Fresenius Medical Care AG (NYSE:FMS)
$ 21.3 -0.03 (-0.14%) Market Cap: 12.50 Bil Enterprise Value: 24.30 Bil PE Ratio: 17.64 PB Ratio: 0.86 GF Score: 78/100

Fresenius Medical Care AG & Co KGaA at JPMorgan Healthcare Conference Transcript

Jan 10, 2023 / 04:15PM GMT
Release Date Price: $17.62 (+3.10%)
David James Adlington
JPMorgan Chase & Co, Research Division - Head of Medical Technology & Services Equity Research

Great. Good morning, everybody. I'm David Adlington, Head of the European Medtech research team for JPMorgan. It's my pleasure to introduce Helen Giza, CEO of Fresenius Medical. There will be an opportunity for questions after the presentation. Thanks. Helen.

Helen Giza
Fresenius Medical Care AG - CEO & Chair of Management Board of Fresenius Med. Care Mgmt AG

Thank you, David, and good morning, everyone. It's great to be back in person after 2 years of remote participation. And it's also my first conference as CEO of Fresenius Medical Care. I joined the company 3 years ago and have worn a number of hats over those past 3 years, initially as CFO, then Chief Transformation Officer. And during that time, I feel like I've really got to know this business really well. And I think whole-heartedly I can say this patient-centric mission-driven company is a great company with great people, great assets and truly a great future. Obviously,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot